Save information for later
Sign Up

Learn About Appendix Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Appendix Cancer Local Doctors?
Elite in Appendix Cancer
Hematology Oncology | Hematology | Oncology
Elite in Appendix Cancer
Hematology Oncology | Hematology | Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English
Offers Telehealth

John Shen is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Shen is rated as an Elite provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Appendix Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Lynch Syndrome.

Tamara L. Musgrave
Advanced in Appendix Cancer
Hematology | Oncology
Advanced in Appendix Cancer
Hematology | Oncology

Ballad Health Cancer Care

743 Island Road, 
Bristol, VA 
Languages Spoken:
English
Offers Telehealth

. Dr. Musgrave is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. Her top areas of expertise are Paget Disease of the Breast, Thrombocytopenia, Neuroendocrine Tumor, and Angiosarcoma.

 
 
 
 
Learn about our expert tiers
Learn More
Adam P. Siegel
Advanced in Appendix Cancer
Hematology | Oncology
Advanced in Appendix Cancer
Hematology | Oncology

Vince Lombardi Cancer Clinic

36500 Aurora Dr, 
Summit, WI 
Languages Spoken:
English
Offers Telehealth

Adam Siegel is a Hematologist and an Oncologist in Summit, Wisconsin. Dr. Siegel is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Adult T-Cell Leukemia, Angiosarcoma, and Inflammatory Breast Cancer.

What are the latest Appendix Cancer Clinical Trials?
A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid Tumors

Summary: This is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors with particular focus on Colorectal carcinoma (CRC).

Match to trials
Find the right clinical trials for you in under a minute
Get started
Development and Clinical Translation of immunoPET Imaging Probes for Digestive System Carcinoma

Summary: The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.